Clarithromycin and simvastatin — GPhC CRA MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: A — Clarithromycin can increase simvastatin exposure and myopathy risk
Clarithromycin strongly inhibits metabolism of simvastatin, increasing the risk of myopathy and rhabdomyolysis. The prescriber should consider an alternative antibiotic or temporarily withholding the statin. The patient should be counselled to report muscle pain, weakness or dark urine.
Reference: BNF